
    
      The study is a Prospective, Open-lable, Multi-center, Randomized trial. 2000 primary coronary
      artery disease patients will be enrolled with a 1:1 randomization ratio(AVI:1000,Firebird
      2:1000) at approximately 40 sites, Subject follow-up be at 30 days, 6 months, 9 months, 12
      months, 2-5 years after procedure.
    
  